Urinary Tract Infection Therapeutic Market Anticipated to Surge on Novel Antibiotics The urinary tract infection therapeutic market encompasses a broad range of antibiotic products, vaccines, and supportive therapies designed to prevent and treat infections of the bladder, urethra, ureters, and kidneys. Key product offerings include β-lactams, fluoroquinolones, sulfonamides, and novel antimicrobial agents that target antibiotic-resistant strains, providing improved efficacy and reduced recurrence rates. These therapies offer advantages such as shorter treatment durations, fewer side effects, and enhanced patient compliance. Growing awareness of antibiotic stewardship, coupled with rising incidence of complicated Urinary Tract Infection Therapeutic Market research (UTIs) among diabetic and immune-compromised patients, underscores the need for innovative solutions. https://www.coherentmarketinsights.com/market-insight/urinary-tract-infection-treatment-market-1178